Related Experiment Video
Updated: Feb 15, 2026
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
LIM kinase 1 serves an important role in the multidrug resistance of osteosarcoma cells
Jian-Zeng Yang1,2, Li-Hong Huang3, Rui Chen1
1Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Abstract:
Multidrug resistance (MDR) is a major challenge for the management of the majority of cancers. The precise molecular mechanisms of MDR remain elusive. In a previous study, a multidrug resistant osteosarcoma model [MG63/vincristine (VCR)] was established by intermittent exposure of MG63 cells to gradually increasing concentrations of VCR. These cells exhibited cross-resistance to multiple structurally and mechanistically unrelated chemotherapeutic agents. The development of MDR was associated with increased expression of LIM kinase 1 (LIMK1). Compared with that in normal human fetal osteoblasts (hFOB) 1.19, the messenger RNA and protein expression of LIMK1 was significantly elevated both in MG63 and U2OS osteosarcoma cells. To observe the expression pattern of LIMK1 in osteosarcoma, immunohistochemical analyses were performed on specimens derived from 6 patients. The results indicated that LIMK1 was expressed to a greater extent in the tumor parenchyma than in the mesenchyme. The role of LIMK1 in MDR was confirmed by transfecting plasmids coding LIMK1-small interfering RNA (siRNA), wild-type-LIMK1 or empty vector into MG63/VCR cells, and measuring the expression of LIMK1 and multidrug resistance protein 1 (MDR1), also known as P-gycoprotein (P-gp). The results demonstrated that the level of MDR1/P-gp was positively correlated with the level of LIMK1. This correlation was also shown with the doxorubicin efflux assay and by measuring apoptosis. Specifically, after 6 h of incubation with VCR, 25.6% of the cells transfected with the LIMK1-siRNA plasmid were apoptotic compared with 6.2% in the empty vector group and 1.3% in the group of cells transfected with the wild-type-LIMK1 plasmid. Thus, it was concluded that LIMK1 serves a key role in the MDR of osteosarcoma and functions through MDR1.
Insights
Multidrug resistance (MDR) in osteosarcoma is linked to elevated LIM kinase 1 (LIMK1) expression. Inhibiting LIMK1 increases chemotherapy effectiveness by reducing multidrug resistance protein 1 (MDR1) levels.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Multidrug resistance (MDR) poses a significant challenge in cancer chemotherapy, particularly in osteosarcoma.
- The molecular mechanisms underlying MDR are not fully understood.
- Previous studies established a multidrug resistant osteosarcoma cell model (MG63/vincristine) exhibiting cross-resistance to various agents.
Purpose of the Study:
- To investigate the role of LIM kinase 1 (LIMK1) in the development of multidrug resistance in osteosarcoma.
- To elucidate the relationship between LIMK1 expression and the expression of multidrug resistance protein 1 (MDR1)/P-glycoprotein (P-gp).
Main Methods:
- Establishment of a multidrug resistant osteosarcoma cell line (MG63/VCR).
- Quantitative analysis of LIMK1 mRNA and protein expression in osteosarcoma cells and normal cells.
- Immunohistochemical analysis of LIMK1 expression in patient-derived osteosarcoma specimens.
- Gene manipulation using LIMK1-small interfering RNA (siRNA) and wild-type LIMK1 plasmids in MG63/VCR cells.
- Assessment of MDR1/P-gp expression, doxorubicin efflux, and apoptosis rates.
Main Results:
- LIMK1 expression was significantly elevated in osteosarcoma cells (MG63, U2OS) compared to normal osteoblasts (hFOB 1.19).
- Immunohistochemistry revealed higher LIMK1 expression in osteosarcoma tumor parenchyma.
- Downregulation of LIMK1 using siRNA led to decreased MDR1/P-gp expression and increased sensitivity to vincristine.
- Upregulation of LIMK1 enhanced MDR1/P-gp levels, correlating with reduced apoptosis and increased drug resistance.
- A positive correlation was observed between LIMK1 levels and MDR1/P-gp expression.
Conclusions:
- LIM kinase 1 (LIMK1) plays a critical role in the multidrug resistance of osteosarcoma.
- LIMK1 contributes to MDR by modulating the expression of MDR1/P-glycoprotein.
- Targeting LIMK1 may represent a potential therapeutic strategy to overcome drug resistance in osteosarcoma.
More Related Videos
Related Concept Videos
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
01:29Self-Serving Bias
01:18Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
01:26Receptor Tyrosine Kinases
01:22Resistivity